You are here

Home » Content

VETERİNER FARMAKOLOJİVE TOKSİKOLOJİDE TRANSPORT PROTEİNLER

Transport Proteins in Veterinary Pharmacology And Toxicology

Journal Name:

  • İstanbul Üniversitesi Veteriner Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Active transport is one of the important process for drug dispositions. Specific membrane transporters serve as a carrier for both surface of epithelial and endothelial cells membrane at the active transport which is against to concentration gradient. These transport proteins are coded by two major super gene family called ABC Super family (ATP-binding family) and SLC Super Family (Solute Carrier Family). These proteins’ cellular localization, structure and function are demonstrated at recent investigations especially on knock-out mice. For the first time P-gp, is a member of ABC super family, was described in tumor cells which have resistance against the antineoplastic drugs. It is shown that P-gp has a vital role at physiological process by transporting endogen molecules. Furthermore, it has been shown that it has an important function at the pharmacokinetic of xenobiotics. At this review we will focus on pharmacokinetic interaction that could be occur in absorption, distribution, biotransformation and elimination, because of competition for binding to same transport protein with examples related to veterinary practices as far as possible. Thus, the role of transport proteins in pharmacokinetics of drugs and toxins which have veterinary importance will be underlined
Bookmark/Search this post with
Abstract (Original Language): 
Aktif taşıma, ilaçların dağılımında önemli yolaklardan biridir. Konsantrasyon farkına karşı olan bu tip geçişte endotel ve epitel hücrelerin her iki yüzünde bulunan spesifik taşıyıcıproteinler görev alır. Taşımaya aracılık eden proteinler ABC (ATP-binding Casette Family) ve SLC (Solute Carrier family) süper ailesi olmak üzere 2 büyük gen ailesi tarafından kodlanırlar. Bu proteinlerin hücresel lokalizasyonları, yapıları ve fonksiyonlarıözellikle knock-out farelerde gösterilmiştir. Taşıyıcıproteinlerden ABC Süper ailesi üyesi olan P-glikoprotein, ilk olarak kanser ilaçlarına karşıdirençli tümör hücrelerinde tanımlanmıştır. P-glikoprotein’in endojen maddelerin taşınmasına aracılık ederek fizyolojik proseslerde rol aldığıve yaşamsal öneme sahip olduğu belirlenmiştir. Ayrıca bu proteinlerin ilaç farmakokinetiğinde de önemli rol oynadıkları gösterilmiştir. Bu yazıda mümkün olduğunca veteriner pratiğe yönelik örneklerle; emilim, dağılım, metabolizma ve atılım sırasında aynıtaşıyıcıproteine yarışma nedeniyle oluşabilecek farmakokinetik etkileşmeler açıklanmaya çalışılacak böylelikle veteriner farmakoloji ve toksikoloji yönünden öneme sahip ilaç ve zehirlerin farmakokinetiğinde taşıyıcıproteinlerin rolü vurgulanacaktır
FULL TEXT (PDF): 
PDF icon arastirmax-veteriner-farmakolojive-toksikolojide-transport-proteinler.pdf
  • 3
9-17
  • Turkish

REFERENCES

References: 

1. Amatori,F.M., Meucci, V.,Giusiani,M., Soldani, G., Corazza, M.,Giorgi, M. Effect of
Grapefruit Juice on the Pharmacokinetics of Cyclosporine inDogs.Vet Rec, 2004; 154, 190-181
2. Benet, L.Z., Cummins, C.L., Wu, C.Y.Unmasking the Dynamic Interplay Between Efflux
Transporters and Metabolic Enzymes. Int J Pharm, 2004;277, 3-9
3. Breedveld,P., Pluim, D., Cipriani, G., Wielinga, P., Tellingen, O., Schinkel, A.H.,
Schellens, J.H.M. The Effects of Bcrp1 (Abcg2) on the In vivo Pharmacokinetics and Brain
Penetration of Imatinib Mestylate (Gleevec): Implacations for the Use of Breast Cancer
Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib
in Patients. Cancer Res, 2005; 65(7), 2577-2582
4. Brunton, LL, Parker, KL, Buxton, I.L.O. and Blumenthal, D.K. (Eds)Goodman &
Gilman's The Pharmacological Basis of Therapeutics, 11.baskı(Online). Erişim tarihi 16
Ekim 2006 www.accessmedicine.com
Murat YILDIRIM, Elif ŞAHİN 16
5. Cascorbi, I. Role of pharmacogenetics of ATP-binding cassette transporters in
pharmacokinetics of drugs. Pharmacol Therapeut, 2006
6. Deeley,R.G., Cole,S.P.C.Substrate recognition and transport by multidrug resistance
protein 1 ( ABCC1). FEBS Lett, 2006; 580, 1103-1111
7. Geyer, J., Klintzsch, S., Meerkamp, K., Wöhlke,A., Distl, O., Moritz, A.Detection of of
the nt 230 (del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin
toxicosis, breed disposition and microsatellite analysis. J.Vet.Pharmacol. Therap., 2007; 30,
482-485
8. Giorgi, M., Meucci, V., Vaccaro, E., Mengozzi, G., Giusiani, M., Soldani, G.Effect of
liquid and freze-dried grapefruit juice on the pharmacokinetics of praziquentel and its
metabolite 4’-OH praziquantel in beagledogs. Pharmacol Res, 2003; 47, 87-92
9. Jonker, J.W., Smit,J.W., Brinkhuis R.F., Maliepaard, M., Beijnen, J.H., Schellens
J.H.M., Schinkel,A.H. Role of breast cancer resistance protein in the bioavaillability and
fetal penetration of topotecan. J Natl Cancer I, 2000; 92(20), 1651-1656
10. Haritova, A.M., Schrıckx, J., Lashev, L., Fınk-Gremmels, J.ABC Efflux Transporters: P-gp,MRP2 and BCRP- the 3
rd
Dimension in Kinetic not only of Fluoroquinolones. Bulg J Vet
Med, 2006; 9(4), 223-242
11. Kaya, S. Farmakokinetik. Veteriner Hekimliğinde Farmakoloji. Ed. Kaya, S., Pirinçci, İ.,
Bilgili, A., Ankara, Medisan Yayınları, 2002, 60-65
12. Lancet ,J., Baer, M.R., Cripe, L.D., et al: Phase I/II Pharmacodynamic Study of the P-glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with
Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with
Acute Myeloid Leukemia (AML). The American Society of Hematology 48th Annual
Meeting and Exposition; .2006; Aralık 9-12,; Orlando, FL. Abstract 422.
13. Lin, J.H., Chiba, M., Chen, I., Nıshime, J.A., Deluna, F.A., Yamazakı, M.,Lin, Y.J.
Effect of Dexamethasone on the Intestinal First-pass Metabolism of Indınavir in Rats:
Evidence of Cytocrome P-450 a and P-glycoprotein Induction. Drug Metab Dispos, 1999;
27 (10) , 1187-1193
14. Mao, Q., Unadkat, J.D.Role of the Breast Cancer Resistance Protein (ABCG2) in Drug
Transport. AAPS J, 2005; 7(1) Article 12, E118-E129.
15. McEntee, M., Silverman, J.A., Rassnick, K., Zgola, M., Chan,A.O., Tau, P.T., Page,
R.L. Enhanced Bioavailability of Oral Docetaxel by Co-adminitration of Cyclosporin A in
Dogs and Rats. Vet Comp Oncol. 2003; 2,105-112
16. Mealey, K.L.Therapeutic Implications of the MDR-1 Gene. J. Vet. Pharmacol. Therap.,
2004; 27, 257-264
17. Miller, D.S.Xenobiotic Export Pumps, Endothelin Signaling, and Tubular Nephrotoxicants-A Case of Molecular Hijacking. J Biochem Mol Toxicol, 2002;16(3), 121-127
18. Mizuno, N., Niwa. T., Yotsumoto, Y., Sugiyama, Y. Impact of Drug Transporter Studies
on Drug Discovery and Development. Pharmocol Rev 2003; 55(3), 425-461.
19. Pulido, M.M., Molina, A.J., Merino, G., Mendoza, G., Prieto, J.G., Alvarez, A.I.
Interaction of Enrofloxacin with Breast Cancer Resistance Protein (BCRP/ABCG2):
Influence of Flavonoids and Rolein Milk Secretion in Sheep. J. Vet. Pharmacol. Therap.,
2006; 29, 279-287
20. Sadeque, A.J.M., Wandel, C., He, H., Shah, S.,Woc, A.J.J. Increased Drug Delivery to the
Brain by P-glycoprotein Inhibition.Clin Pharmacol Ther. 2000;68,231-237
21. Sartor, L.L., Bentjen, S.A., Trepanier, L.,Mealey, K.L.Loperamide Toxicity in a Collie
with MDR1 Mutation Associated with IvermectinSensitivity. J. Vet. Intern. Med. 2004; 18,
117-118
22. Schinkela, A.H., Smita J.M.M., Tellingenb, O., Beijnenc, J.H., Wagenaara, E.,
Deemtera, L., Mola, C.A.A.M., Valkd, M.A., Robanus-Maandagd, E.C., Rieled, H.P.J.,
Bernsd and P. Borsta A.J.M.. Disruption of the Mouse mdr1a P-glycoprotein gene Leads to
a Deficiency in the Blood-brain Barrier and toIncreased Sensitivity to Drugs. Cell, 1994;
77(4), 491-502.
23. Takano, M.,Yumoto, R., Murakami, T.Expression and Function of Efflux Drug
Transporters in the Intestine. Pharmacol Therapeut, 2006; 109, 137-161
24. van Herwaarden, A.E., Wagenaar, E., Karnekamp, B., Merino, G., Jonker, J.W.,
Schinkel, A.H. Breast Cancer Resistance Protein (Bcrp1/Abcg2) Reduces Systemic
Exposure of the Dietary Carcinogens Aflatoxin B1, IQ and Trp-P-1 but also Mediates Their
Secretion into Breast Milk, Carcinogenesis. 2006; 27(1), 123-130

Thank you for copying data from http://www.arastirmax.com